Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Edesa Biotech, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 28 | 33 | +5 |
| Shares | 2.64M | 3.75M | +1.11M (+42.0%) |
| Value | $13.8M | $30.0M | +$16.2M (+117.0%) |
New holders (11)
Institutions that held Edesa Biotech, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 561,751 | $4.57M | 0.00% |
| Boxer Capital Management, LLC | 205,000 | $1.67M | 0.13% |
| XTX Topco Ltd | 35,352 | $287.4K | 0.00% |
| HRT Financial LP | 31,531 | $256.0K | 0.00% |
| Two Sigma Investments, LP | 14,032 | $114.1K | 0.00% |
| Federation des caisses Desjardins du Quebec | 2,595 | $21.1K | 0.00% |
| Morgan Stanley | 1,400 | $11.4K | 0.00% |
| BNP Paribas Arbitrage, SA | 1,122 | $9.12K | 0.00% |
| JPMorgan Chase & Co | 1,130 | $8.67K | 0.00% |
| Jones Financial Companies LLLP | 8 | $66 | 0.00% |
| Northwestern Mutual Wealth Management Co | 4 | $33 | 0.00% |
Sold out (6)
Institutions that held Edesa Biotech, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Commonwealth Equity Services, LLC | 35,003 | $183.1K |
| Scientech Research LLC | 30,534 | $159.7K |
| Virtu Financial LLC | 26,275 | $137.0K |
| Schonfeld Strategic Advisors LLC | 19,650 | $102.8K |
| Citigroup Inc | 487 | $2.55K |
| Dogwood Wealth Management LLC | 1 | $5 |